| Journal | Comprehensive psychiatry |
| Study Type | Clinical Study |
| Population | Human participants |
This position statement addresses a critical gap in OCD treatment guidelines for the most severe cases requiring hospitalization. While cannabis is increasingly used by patients with OCD and anxiety disorders, there are no established protocols for managing cannabis use during psychiatric inpatient admissions for OCD.
This expert consensus statement from the International College of Obsessive-Compulsive Spectrum Disorders outlines evidence-based recommendations for hospitalizing patients with severe OCD. The authors review indications for admission, including treatment-refractory cases and safety concerns, and describe inpatient treatment approaches showing significant reductions in OCD severity. The statement emphasizes that hospitalization remains uncommon for OCD compared to other psychiatric conditions but can be necessary when outpatient pharmacological and psychological interventions fail or pose safety risks.
“I regularly encounter patients using cannabis for OCD symptoms, yet this comprehensive position statement makes no mention of cannabis considerations during inpatient care. This represents a notable clinical blind spot given the prevalence of cannabis use in this population.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
This study item was assembled from normalized source metadata and pipeline scoring.